arrow
U

Ulrich Steidl

Yeshiva University
H指数:58
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploiting an epigenetic resistance mechanism to PI3-kinase inhibition in leukemic stem cells

利用表观遗传耐药机制克服白血病干细胞中PI3-激酶抑制

Leukemia
IF13.4
2026-09-280
OAAI
Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis

TGF-β1通过重塑β-球蛋白和MYC增强子染色质驱动缺陷性红细胞生成

2026-05-130
OAAI
Degrading SMARCA2/4 Relieves the Differentiation Block in AML Via Chromatin Alterations Affecting S100A8/9

通过影响S100A8/9的染色质改变,降解SMARCA2/4可解除急性髓系白血病(AML)的分化阻滞

BLOOD
IF23.1
2024-11-051
PRE
Post-Transplantation Cyclophosphamide and Abatacept Graft-Versus-Host-Disease Prophylaxis Shows Improved Outcomes in North American Adult T-Cell Leukemia/Lymphoma

移植后环磷酰胺和阿巴西特移植物抗宿主病预防显示出在北美成人T细胞白血病/淋巴瘤中改善的结局

BLOOD
IF23.1
2024-11-050
PRE
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses

谷氨酰胺酶抑制联合氮杂胞苷治疗骨髓增生异常综合征: 1b/2期临床试验及相关分析

2024-09-190
PRE
An iron rheostat controls hematopoietic stem cell fate
2024-03-015
OAAI
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
2024-02-201
OAAI
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis
2023-12-266
OAAI
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
2022-08-3040
OA
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer (vol 15, 70, 2022)
2022-07-260
OAAI